• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Mcmaken Kurt B was granted 2,794 shares, increasing direct ownership by 204% to 4,162 units (SEC Form 4)

    5/27/25 4:42:50 PM ET
    $DD
    Major Chemicals
    Industrials
    Get the next $DD alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    McMaken Kurt B

    (Last) (First) (Middle)
    CHESTNUT RUN PLAZA 730
    974 CENTRE ROAD

    (Street)
    WILMINGTON DE 19805

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    DuPont de Nemours, Inc. [ DD ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/22/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/22/2025 A 2,794 A $0 4,162 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Peter W. Hennessey by Power of Attorney 05/27/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DD

    DatePrice TargetRatingAnalyst
    4/15/2025$75.00Underperform → Neutral
    BofA Securities
    4/14/2025$81.00Sector Weight → Overweight
    KeyBanc Capital Markets
    2/13/2025$85.00 → $89.00Underweight → Equal Weight
    Barclays
    1/17/2025$91.00Peer Perform → Outperform
    Wolfe Research
    10/7/2024$88.00 → $84.00Equal Weight → Underweight
    Barclays
    5/28/2024$85.00 → $95.00Neutral → Buy
    Citigroup
    5/24/2024$80.00 → $103.00Equal Weight → Overweight
    Wells Fargo
    5/23/2024$96.00Market Perform → Outperform
    BMO Capital Markets
    More analyst ratings

    $DD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Lowery Frederick M. was granted 580 shares, increasing direct ownership by 2% to 32,579 units (SEC Form 4)

      4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

      6/3/25 5:10:02 PM ET
      $DD
      Major Chemicals
      Industrials
    • Director Cutler Alexander M was granted 749 shares, increasing direct ownership by 1% to 72,865 units (SEC Form 4)

      4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

      6/3/25 5:09:34 PM ET
      $DD
      Major Chemicals
      Industrials
    • Director Curtin Terrence R was granted 487 shares, increasing direct ownership by 2% to 30,370 units (SEC Form 4)

      4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

      6/3/25 5:08:54 PM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • DuPont upgraded by BofA Securities with a new price target

      BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00

      4/15/25 8:43:17 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont upgraded by KeyBanc Capital Markets with a new price target

      KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00

      4/14/25 8:04:47 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont upgraded by Barclays with a new price target

      Barclays upgraded DuPont from Underweight to Equal Weight and set a new price target of $89.00 from $85.00 previously

      2/13/25 8:08:02 AM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DuPont Completes Qnity™ Board of Directors

      Mark Blinn announced as director and chairman and Yi Hyon Paik as director WILMINGTON, Del., June 11, 2025  /PRNewswire/ -- DuPont (NYSE:DD) today announced that Mark A. Blinn and Dr. Yi Hyon Paik will become members of the future board of directors (the "Qnity Board") for Qnity Electronics, Inc., the planned, independent Electronics public company created from DuPont's intended spin-off.* Mr. Blinn will become chairman of the Qnity Board effective with the spin-off. Mr. Blinn was chief executive officer, president, and director of Flowserve Corporation until his retirement in

      6/11/25 8:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Innovators in Semiconductor Materials Named 2025 Heroes of Chemistry

      Breakthrough in Semiconductor Lithography Recognized by the American Chemical Society WILMINGTON, Del., June 10, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that 13 of its current and former scientists and engineers have been named 2025 Heroes of Chemistry by the American Chemical Society (ACS) for an innovative program that progressed semiconductor lithography. The award recognizes the collaborative development of embedded barrier layer technology, a transformative advancement in 193 nm immersion lithography that significantly improved chip fabrication processes by

      6/10/25 11:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Expands Healthcare Manufacturing Site in Costa Rica, Adding Sterile Packaging Capacity

      The 16,000-square-foot expansion enhances DuPont's global sterile operations, increases the capacity of the manufacturing site's existing medical tubing operations, and enables Costa Rica's first-ever production of sterile healthcare packaging. WILMINGTON, Del., June 5, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that it has expanded its sterile operations via an addition to its healthcare manufacturing facility in Heredia, Costa Rica, enabling the site to produce sterile packaging for the global medical device industry while also increasing the capacity of the site's existing medical tubing operations.

      6/5/25 9:00:00 AM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Leadership Updates

    Live Leadership Updates

    See more
    • DuPont Announces Appointment of Kurt McMaken to Board of Directors

      WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors," said DuPont Executive Chairman Ed Breen. "Kurt's global business expertise in the manufacturing sector and extensive background in finance and strategic planning make him well suited to help guide DuPont's growth and value creation strategies. We look forward to his c

      2/21/25 4:15:00 PM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Announces Two Technology Leaders as DuPont Laureates

      Dr. Deyan Wang and Nicholas Sands Recognized for a Career of Innovation and Business Impact; Achieve Highest Technical Level in the Company WILMINGTON, Del., Oct. 10, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced that two of its technology leaders have achieved the professional distinction of DuPont Laureate, the company's most distinguished technical designation. The newly appointed Laureates are Dr. Deyan Wang, DuPont Electronics & Industrial and Nicholas (Nick) Sands of DuPont Water & Protection. "I'm tremendously honored to recognize Deyan and Nick, two of DuPont's

      10/10/24 9:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont to Acquire Donatelle Plastics Incorporated

      Transaction deepens healthcare offerings in medical device solutions WILMINGTON, Del., June 25, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has signed an agreement to acquire Donatelle Plastics Incorporated, a leading medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. "Our healthcare strategy is focused on offering a comprehensive sui

      6/25/24 9:00:00 AM ET
      $DD
      Major Chemicals
      Industrials